MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev D.
Zhang P, et al. Among authors: calin gg.
Cancer Res. 2012 Apr 1;72(7):1751-62. doi: 10.1158/0008-5472.CAN-11-3027. Epub 2012 Feb 20.
Cancer Res. 2012.
PMID: 22350414
Free PMC article.